News | August 25, 2021
Cipla forms JV with Kemwell Biopharma
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
First and only therapy approved by the FDA for the treatment of pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis
Zydus was the first to file an ANDA for Tofacitinib extended-release tablets 22 mg and currently holds 180-day exclusivity on this strength
Cosentyx is a proven treatment, supported by long-term five-year sustained efficacy and safety data across several inflammatory conditions and with more than 500,000 patients treated worldwide since launch
Lenalidomide is used to treat cancer and also some anaemia disorders
The group has a total of 320 ANDA approvals
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
The aim is to create new genomics solutions that could combat cancer and advance market access
The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
Filing for WHO Emergency Use Authorisation this month
Subscribe To Our Newsletter & Stay Updated
